Home › Therapeutic areas › Hematology › Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria (1 companies)
Companies with an active program in Paroxysmal Nocturnal Hemoglobinuria.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| NVCT | Nuvectis Pharma | HematologyOncology+1 Rare | 1 | Phase 3 | $719M | 9 |
No companies match.